• Published On : Jan-2017 |
  • Pages : 120 Pages |
  • Format :

1. Executive Summary

2. Crohn's Disease Market Overview
   2.1. Introduction
        2.1.1. Market Definition
        2.1.2. Market Taxonomy
   2.2. Crohn's Disease Market Dynamics
        2.2.1. Drivers
        2.2.2. Restraints
        2.2.3. Opportunity
        2.2.4. Value Chain
   2.3. Epidemiology
   2.4. Inflammatory Bowel Disease (IBD) Stepwise Treatment Paradigm
   2.5. Medications for Crohn’s Disease- Current & Future Therapies

3. Global Crohn's Disease Market Forecast, 2016–2024
   3.1. Introduction
        3.1.1. Y-o-Y Growth Projections
        3.1.2. Absolute $ Opportunity
   3.2. Crohn's Disease Market Trends

4. Global Crohn's Disease Market Analysis, By Drug Type
   4.1. Introduction
        4.1.1. Basis Point Share (BPS) Analysis By Drug Type
        4.1.2. Y-o-Y Growth Projections By Drug Type
   4.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Drug Type
        4.2.1. Anti-inflammatory drugs
        4.2.2. Immune system suppressors
        4.2.3. Antibiotics
        4.2.4. Biologics
        4.2.5. Anti-diarrheal
        4.2.6. Pain relievers
   4.3. Attractiveness Analysis By Drug Type

5. Global Crohn's Disease Market Analysis, By Distribution Channel
   5.1. Introduction
        5.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
        5.1.2. Y-o-Y Growth Projections By Distribution Channel
   5.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Distribution Channel
        5.2.1. Hospitals
        5.2.2. Retail Pharmacies
        5.2.3. Online Pharmacies
        5.2.4. Drug Stores
   5.3. Market Attractiveness Analysis, By Distribution Channel

6. Global Crohn's Disease Market Analysis, By Region 
   6.1. Introduction
        6.1.1. Basis Point Share (BPS) Analysis By Region
        6.1.2. Y-o-Y Growth Projections By Region
   6.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Region
        6.2.1. North America
        6.2.2. Europe
        6.2.3. Asia Pacific
        6.2.4. Latin America
        6.2.5. Middle East and Africa (MEA)
   6.3. Market Attractiveness Analysis By Region

7. North America Crohn's Disease Market Analysis and Forecast
   7.1. Introduction
        7.1.1. Basis Point Share (BPS) Analysis By Country
        7.1.2. Y-o-Y Growth Projections By Country
        7.1.3. Market Attractiveness Analysis By Country
   7.2. Market Size (US$ Mn) Forecast By Country
        7.2.1. U.S.
        7.2.2. Canada
   7.3. Market Size (US$ Mn) Forecast By Drug type
        7.3.1. Anti-inflammatory drugs
        7.3.2. Immune system suppressors
        7.3.3. Antibiotics
        7.3.4. Biologics
        7.3.5. Anti-diarrheal
        7.3.6. Pain relievers
   7.4. Market Size (US$ Mn) Forecast By Distribution Channel
        7.4.1. Hospitals
        7.4.2. Retail Pharmacies
        7.4.3. Online Pharmacies
        7.4.4. Drug Stores
   7.5. Market Attractiveness Analysis
        7.5.1. By Country
        7.5.2. By Drug Type
        7.5.3. By Distribution Channel

8. Latin America Crohn’s Disease Market Analysis and Forecast
   8.1. Introduction
        8.1.1. Basis Point Share (BPS) Analysis By Country
        8.1.2. Y-o-Y Growth Projections By Country
        8.1.3. Market Attractiveness Analysis By Country
   8.2. Market Size (US$ Mn) Forecast By Country
        8.2.1. Brazil
        8.2.2. Mexico
        8.2.3. Latin America
   8.3. Market Size (US$ Mn) Forecast By Drug type
        8.3.1. Anti-inflammatory drugs
        8.3.2. Immune system suppressors
        8.3.3. Antibiotics
        8.3.4. Biologics
        8.3.5. Anti-diarrheal
        8.3.6. Pain relievers
   8.4. Market Size (US$ Mn) Forecast By Distribution Channel
        8.4.1. Hospitals
        8.4.2. Retail Pharmacies
        8.4.3. Online Pharmacies
        8.4.4. Drug Stores
   8.5. Market Attractiveness Analysis
        8.5.1. By Country
        8.5.2. By Drug Type
        8.5.3. By Distribution Channel

9. Europe Crohn’s Disease Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Basis Point Share (BPS) Analysis By Country
        9.1.2. Y-o-Y Growth Projections By Country
        9.1.3. Market Attractiveness Analysis By Country
   9.2. Market Size (US$ Mn) Forecast By Country
        9.2.1. Germany
        9.2.2. U.K.
        9.2.3. France
        9.2.4. Italy
        9.2.5. Spain
        9.2.6. Russia
        9.2.7. Rest of Europe
   9.3. Market Size (US$ Mn) Forecast By Drug type
        9.3.1. Anti-inflammatory drugs
        9.3.2. Immune system suppressors
        9.3.3. Antibiotics
        9.3.4. Biologics
        9.3.5. Anti-diarrheal
        9.3.6. Pain relievers
   9.4. Market Size (US$ Mn) Forecast By Distribution Channel
        9.4.1. Hospitals
        9.4.2. Retail Pharmacies
        9.4.3. Online Pharmacies
        9.4.4. Drug Stores
   9.5. Market Attractiveness Analysis
        9.5.1. By Country
        9.5.2. By Drug Type
        9.5.3. By Distribution Channel

10. Asia Pacific Crohn’s Disease Market Analysis and Forecast
    10.1. Introduction
         10.1.1. Basis Point Share (BPS) Analysis By Country
         10.1.2. Y-o-Y Growth Projections By Country
         10.1.3. Market Attractiveness Analysis By Country
    10.2. Market Size (US$ Mn) Forecast By Country
         10.2.1. China
         10.2.2. Japan
         10.2.3. India
         10.2.4. Australia and New Zealand
         10.2.5. ASEAN
         10.2.6. Rest of Asia-Pacific
    10.3. Market Size (US$ Mn) Forecast By Drug type
         10.3.1. Anti-inflammatory drugs
         10.3.2. Immune system suppressors
         10.3.3. Antibiotics
         10.3.4. Biologics
         10.3.5. Anti-diarrheal
         10.3.6. Pain relievers
    10.4. Market Size (US$ Mn) Forecast By Distribution Channel
         10.4.1. Hospitals
         10.4.2. Retail Pharmacies
         10.4.3. Online Pharmacies
         10.4.4. Drug Stores
    10.5. Market Attractiveness Analysis
         10.5.1. By Country
         10.5.2. By Drug Type
         10.5.3. By Distribution Channel

11. Middle East and Africa (MEA) Crohn’s Disease Market Analysis and Forecast
    11.1. Introduction
         11.1.1. Basis Point Share (BPS) Analysis By Country
         11.1.2. Y-o-Y Growth Projections By Country
         11.1.3. Market Attractiveness Analysis By Country
    11.2. Market Size (US$ Mn) Forecast By Country
         11.2.1. GCC Countries
         11.2.2. South Africa
         11.2.3. Rest of MEA
    11.3. Market Size (US$ Mn) Forecast By Drug type
         11.3.1. Anti-inflammatory drugs
         11.3.2. Immune system suppressors
         11.3.3. Antibiotics
         11.3.4. Biologics
         11.3.5. Anti-diarrheal
         11.3.6. Pain relievers
    11.4. Market Size (US$ Mn) Forecast By Distribution Channel
         11.4.1. Hospitals
         11.4.2. Retail Pharmacies
         11.4.3. Online Pharmacies
         11.4.4. Drug Stores
    11.5. Market Attractiveness Analysis
         11.5.1. By Country
         11.5.2. By Drug Type
         11.5.3. By Distribution Channel

12. Competition Landscape
    12.1. Competition Dashboard
    12.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
    12.3. Global Players
         12.3.1. Allergan, Inc.,
         12.3.2. UCB S.A.
         12.3.3. AbbVie Inc.
         12.3.4. Perrigo Company plc
         12.3.5. Takeda Pharmaceutical Company Limited
         12.3.6. Pfizer Inc.
         12.3.7. Johnson & Johnson Services, Inc.
         12.3.8. Bayer AG
         12.3.9. Ferring B.V.

13. Assumptions and Acronyms Used

14. Research Methodology


List of Tables:

Table 01: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 02: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 03: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2024
Table 04: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 05: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 06: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 07: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 08: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 09: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 10: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 11: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 12: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 13: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 14: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 15: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 16: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 17: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015–2024
Table 18: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024


List of Figures

Figure 01: Global Crohn's Disease Market Value Share By, Region, 2015 A
Figure 02: Global Crohn's Disease Market Value Share By, Drug Type, 2015 A
Figure 03: Global Crohn's Disease Market Value Share By, Distribution Channel, 2015 A
Figure 04: Global Crohn's Disease Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 05: Global Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 06: Global Crohn's Disease Market Share and BPS Analysis (%) By Drug Type, 2016 & 2024
Figure 07: Global Crohn's Disease Y-o-Y growth (%) By Drug Type, 2016–2024
Figure 08: Global Crohn's Disease Market Absolute $ Opportunity By Anti-inflammatory Drugs Segment,
Figure 09: Global Crohn's Disease Market Absolute $ Opportunity By Immune System Suppressors Segment, 2016–2024
Figure 10: Global Crohn's Disease Market Absolute $ Opportunity By Antibiotics Segment, 2016–2024
Figure 11: Global Crohn's Disease Market Absolute $ Opportunity By Biologics Segment, 2016–2024
Figure 12: Global Crohn's Disease Market Absolute $ Opportunity By Anti-diarrheal Segment, 2016–2024
Figure 13: Global Crohn's Disease Market Absolute $ Opportunity By Pain Relievers Segment, 2016–2024
Figure 14: Global Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 15: Global Crohn's Disease Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 16: Global Crohn's Disease Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 17: Global Crohn's Disease Market Absolute $ Opportunity By Hospital Pharmacies Segment,
Figure 18: Global Crohn's Disease Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016–2024
Figure 19: Global Crohn's Disease Market Absolute $ Opportunity By Online Pharmacies Segment, 2016–2024
Figure 20: Global Crohn's Disease Market Absolute $ Opportunity By Drug Stores Segment, 2016–2024
Figure 21: Global Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 22: Global Crohn's Disease Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 23: Global Crohn's Disease Market Share and BPS Analysis (%) By Region, 2016 & 2024
Figure 24: Global Crohn's Disease Y-o-Y growth (%) By Region, 2016–2024
Figure 25: North America Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 26: Latin America Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 27: Europe Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 28: APAC Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 29: Middle East and Africa Crohn's Disease Market Absolute $ Opportunity, 2016–2024
Figure 30: Global Crohn's Disease Market Attractiveness Analysis By Region, 2016–2024
Figure 31: North America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 32: North America Crohn's Disease Market Attractiveness Analysis By Country, 2016–2024
Figure 33: North America Crohn's Disease Y-o-Y growth (%) By Country, 2016–2024
Figure 34: North America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 35: North America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 36: Latin America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 37: Latin America Crohn's Disease Market Attractiveness Analysis By Country, 2016–2024
Figure 38: Latin America Crohn's Disease Y-o-Y growth (%) By Country, 2016–2024
Figure 39: Latin America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 40: Latin America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 41: Europe Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 42: Europe Crohn's Disease Market Attractiveness Analysis By Country, 2016–2024
Figure 43: Europe Crohn's Disease Y-o-Y growth (%) By Country, 2016–2024
Figure 44: Europe Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 45: Europe Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 46: APAC Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 47: APAC Crohn's Disease Market Attractiveness Analysis By Country, 2016–2024
Figure 48: APAC Crohn's Disease Y-o-Y growth (%) By Country, 2016–2024
Figure 49: APAC Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 50: APAC Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 51: MEA Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 52: MEA Crohn's Disease Market Attractiveness Analysis By Country, 2016–2024
Figure 53: MEA Crohn's Disease Y-o-Y growth (%) By Country, 2016–2024
Figure 54: MEA Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016–2024
Figure 55: MEA Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016–2024